首页> 外文期刊>Nephron >The impact of prior multidisciplinary predialysis care on mineral metabolic control among chronic hemodialysis patients.
【24h】

The impact of prior multidisciplinary predialysis care on mineral metabolic control among chronic hemodialysis patients.

机译:先前的多学科透析前护理对慢性血液透析患者的矿物质代谢控制的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Disordered mineral metabolism is independently associated with mortality among chronic dialysis patients. We hypothesized that, upon dialysis start, biochemical markers of mineral metabolism would be better controlled among patients who had received multidisciplinary predialysis care (MDC). METHODS: We conducted a retrospective cohort study of incident hemodialysis patients between 2002 and 2005. Corrected calcium (Ca), phosphate (P), calcium-phosphate product (CaxP), and intact parathyroid hormone (iPTH) at the time of dialysis initiation and over the first year thereafter were compared based on prior MDC receipt. Furthermore, we examined the relationship between the duration of MDC and mineral metabolic parameters. RESULTS: 67 patients received MDC and 84 patients received conventional or no nephrologist-based care. Patients who received MDC had a higher iPTH (p = 0.03) both at dialysis initiation and over the subsequent year while Ca, P, and CaxP were not significantly impacted. Among patients who received MDC, mineral metabolic values at dialysis initiation did not differ by duration of predialysis care. CONCLUSIONS: The receipt of MDC had a limited effect on mineral metabolic profiles at the time of and over the first year following chronic hemodialysis initiation. The survival benefits associated with the receipt of MDC may be mediated by mechanisms other than improved mineral metabolic control.
机译:背景/目的:慢性透析患者的矿物质代谢紊乱与死亡率独立相关。我们假设,在开始透析后,接受多学科透析前治疗(MDC)的患者中矿物质代谢的生化标志物将得到更好的控制。方法:我们对2002年至2005年之间发生的血液透析患者进行了一项回顾性队列研究。在开始和进行透析时,校正了钙(Ca),磷酸盐(P),磷酸钙产品(CaxP)和完整的甲状旁腺激素(iPTH)。然后根据之前的MDC收据比较第一年的收入。此外,我们检查了MDC持续时间与矿物质代谢参数之间的关系。结果:67例患者接受了MDC,84例患者接受了传统的或没有肾脏科医生的护理。接受MDC的患者在透析开始时和随后的一年中均具有较高的iPTH(p = 0.03),而Ca,P和CaxP并未受到显着影响。在接受MDC的患者中,透析开始时的矿物质代谢值随透析前护理时间的不同而不同。结论:在开始慢性血液透析后的第一年及之后的第一年及之后,接受MDC对矿物质代谢的影响有限。与接受MDC相关的生存益处可能是由改善矿物质代谢控制以外的其他机制介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号